Bill Text: MI HB5166 | 2021-2022 | 101st Legislature | Chaptered
Bill Title: Controlled substances: opioids; distribution of opioid antagonists by community based-organizations under a standing order; allow and limit certain liability. Amends sec. 17744e of 1978 PA 368 (MCL 333.17744e).
Spectrum: Partisan Bill (Republican 1-0)
Status: (Passed) 2022-08-17 - Assigned Pa 176'22 With Immediate Effect [HB5166 Detail]
Download: Michigan-2021-HB5166-Chaptered.html
Act No. 176
Public Acts of 2022
Approved by the Governor
July 21, 2022
Filed with the Secretary of State
July 21, 2022
EFFECTIVE DATE: July 21, 2022
state of michigan
101st Legislature
Regular session of 2022
Introduced by Rep. Whiteford
ENROLLED HOUSE BILL No. 5166
AN ACT to amend 1978 PA 368, entitled “An act to protect and promote the public health; to codify, revise, consolidate, classify, and add to the laws relating to public health; to provide for the prevention and control of diseases and disabilities; to provide for the classification, administration, regulation, financing, and maintenance of personal, environmental, and other health services and activities; to create or continue, and prescribe the powers and duties of, departments, boards, commissions, councils, committees, task forces, and other agencies; to prescribe the powers and duties of governmental entities and officials; to regulate occupations, facilities, and agencies affecting the public health; to regulate health maintenance organizations and certain third party administrators and insurers; to provide for the imposition of a regulatory fee; to provide for the levy of taxes against certain health facilities or agencies; to promote the efficient and economical delivery of health care services, to provide for the appropriate utilization of health care facilities and services, and to provide for the closure of hospitals or consolidation of hospitals or services; to provide for the collection and use of data and information; to provide for the transfer of property; to provide certain immunity from liability; to regulate and prohibit the sale and offering for sale of drug paraphernalia under certain circumstances; to provide for the implementation of federal law; to provide for penalties and remedies; to provide for sanctions for violations of this act and local ordinances; to provide for an appropriation and supplements; to repeal certain acts and parts of acts; to repeal certain parts of this act; and to repeal certain parts of this act on specific dates,” by amending section 17744e (MCL 333.17744e), as added by 2016 PA 383.
The People of the State of Michigan enact:
Sec. 17744e. (1) Notwithstanding any provision of this act to the contrary, the chief medical executive in the office of chief medical executive created within the department of health and human services may issue a standing order that does not identify particular patients at the time it is issued for any of the following purposes:
(a) A pharmacist dispensing opioid antagonists to individuals under this section.
(b) A community-based organization or a staff member of the community-based organization distributing opioid antagonists to individuals under this section.
(2) Notwithstanding any provision of this act to the contrary, a pharmacist may dispense or a community-based organization or a staff member of the community-based organization may distribute an opioid antagonist to any individual pursuant to a standing order issued by the chief medical executive under subsection (1) and the rules promulgated under this section.
(3) The following are not liable in a civil action for damages resulting from the dispensing of an opioid antagonist or the administration of or failure to administer the opioid antagonist:
(a) The chief medical executive who issues a standing order
for the opioid antagonist under this section.
(b) A pharmacist who dispenses the opioid antagonist as authorized under this section.
(c) A community-based organization that, or a staff member of the community-based organization who, distributes the opioid antagonist as authorized under this section.
(4) The department, in consultation with the department of health and human services and local health departments, may promulgate rules regarding dispensing, training, distribution, and referral to implement this section.
(5) As used in this section, “community-based organization” means a public or private organization that provides health or human services to meet the needs of a community, including, but not limited to, a nonprofit organization, a social service provider, or an organization providing substance use disorder prevention, treatment, recovery, or harm reduction services. A community-based organization does not include an agency as that term is defined in section 101 of the administration of opioid antagonists act, 2019 PA 39, MCL 15.671.
This act
is ordered to take immediate effect.
Clerk of the House of Representatives
Secretary of the Senate
Approved___________________________________________
____________________________________________________
Governor
